Eiger BioPharmaceuticals, Inc.

NASDAQ:EIGR

1.725 (USD) • At close April 10, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 25.4425.79822.22128.86439.37361.26232.03527.75632.77714.4357.90313.841
Short Term Investments 073.1566.59499.97655.62139.0919.74432.18070.51310.46718.808
Cash and Short Term Investments 25.4498.94888.815128.8494.994100.35341.77959.93632.77784.94818.3732.649
Net Receivables 1.6821.7492.5767.65800000.226000
Inventory 1.5562.8532.6120.09300000000
Other Current Assets 1.28913.9859.3611.2155.391.4920.7120.5810.8733.1350.180.288
Total Current Assets 37.839117.535103.364137.806100.384101.84542.49160.51733.87688.08318.5532.937
Non-Current Assets:
Property, Plant & Equipment, Net 0.6271.2571.2661.8852.2440.1670.0790.0760.0410.7630.3080.122
Goodwill 000000000000
Intangible Assets 000000000000
Goodwill and Intangible Assets 00-0.137000000000
Long Term Investments 0017.26200000.0650002.862
Tax Assets 00.1280.1370.24700000000
Other Non-Current Assets 0.361.2194.513.6562.5110.4360.3120.078-0.0310.2642.2960.008
Total Non-Current Assets 0.9872.60423.0385.7884.7550.6030.3910.2190.011.0272.6042.992
Total Assets 38.826120.139126.402143.594105.139102.44842.88260.73633.88689.1121.15435.929
Liabilities & Equity:
Current Liabilities:
Account Payables 2.1158.9757.7654.646.4145.833.1832.6390.4795.8031.3970.569
Short Term Debt 41.2030.4918.4370.5820.53402.00205.4440.0011.0440
Tax Payables 00000.040.040.0560.0970000
Deferred Revenue 01.3731.8460000.0560-5.4440.8013.0030
Other Current Liabilities 9.96614.28211.85311.40510.0014.1942.0282.649-3.6140.0011.1161.209
Total Current Liabilities 53.28425.12129.90116.62716.94910.0247.2695.2882.3096.6066.561.778
Non-Current Liabilities:
Long Term Debt 039.70824.10231.93231.7125.6213.09114.727010.10200
Deferred Revenue Non-Current 0-39.836-24.23930.94700000000
Deferred Tax Liabilities Non-Current 00.1280.1370.24700000000
Other Non-Current Liabilities 039.70824.102-31.19400.212-13.091-14.7270.0240.2985.48710.293
Total Non-Current Liabilities 039.70824.10231.93231.7125.83213.09114.7270.02410.45.48710.293
Total Liabilities 53.28464.82954.00348.55948.65935.85620.3620.0152.33317.00612.04712.071
Equity:
Preferred Stock 0000000022.56789.1160.09852.274
Common Stock 0.0010.0440.0350.0340.0240.0190.0110.0080.0020.02300
Retained Earnings -512.156-437.193-340.417-306.5-241.449-171.197-118.806-76.358-190.852-146.439-112.586-92.591
Accumulated Other Comprehensive Income/Loss -0.169-0.3-0.149-0.0080.042-0.025-0.003-0.015-22.567-0.0080.0020.009
Other Total Stockholders Equity 497.866492.759412.93401.509297.863237.795141.32117.086199.836129.41861.59364.166
Total Shareholders Equity -14.45855.3172.39995.03556.4866.59222.52240.72131.55372.1049.10723.858
Total Equity -14.45855.3172.39995.03556.4866.59222.52240.72131.55372.1049.10728.672
Total Liabilities & Shareholders Equity 38.826120.139126.402143.594105.139102.44842.88260.73633.88689.1121.15435.929